Matthew Pillar
Matthew Pillar is chief editor at BioProcess Online. He's spent the past 20 years covering tech-centric industries as they’ve navigated AI, machine learning, IoT, and other emerging technologies. His chief and executive editorial experience includes tenures with Software Executive, Channel Executive, Business Solutions and ISR magazines, where he routinely interviewed international technology builders and influencers. Pillar has spoken on emerging technologies and their implications at major events for leading tech vendors including NetSuite, Oracle, SAP, and others.
Connect with Pillar on LinkedIn at linkedin.com/in/matthewpillar/
ARTICLES BY MATTHEW PILLAR
- Update On The Adoption Of Advanced Rapid Microbiology Methods In Biopharma
- The Perilous Development Of A Potential Biologic Blockbuster
- CDER-ETP: A Resource For Innovative Biopharma Firms
- A Disruptive Approach To Oncology Therapy Development
- How BlueWillow Biologics Is Pioneering Mucosal Vaccine Tech
- Alternative Funding For Startup Biotechs
- International Reference Pricing: The Answer To Rising Drug Costs?
- Early-Stage Biopharma Funding Advice From A Leading VC
- How The Medical Innovation Act Could Stifle Medical Innovation
- Outsourcing Insights From A Tech Transfer Veteran
- Solving Pharma’s Public Opinion Crisis
- Why EU’s New Med Device Regs Matter To Biopharma
- Abcentra Chief Looks Beyond The Clinical Horizon
- Does Gender Disparity In Biotech Really Matter?
- AbbVie’s Dr. Howard Jacob: Improving The Drug Pipeline With Genomics
- Inside NIIMBL And Its New FDA Partnership
- Are Drones Feasible In Biopharma?